Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk (original) (raw)
Mechanisms of platelet recovery in ITP associated with therapy
Alan Lazarus
Annals of Hematology, 2010
View PDFchevron_right
Distinct pathways regulate Syk activation downstream of ITAM and hemITAM receptors in platelets
Victor Wang
View PDFchevron_right
The Role of the Human Fc Receptor FcγRIIA in the Immune Clearance of Platelets: A Transgenic Mouse Model
Saul Surrey
The Journal of Immunology, 1999
View PDFchevron_right
Functional expression of IgA receptor Fc RI on human platelets
Andrew Gibson
Journal of Leukocyte Biology, 2008
View PDFchevron_right
Functional expression of IgA receptor FcαRI on human platelets
Fenglong Xie
Journal of Leukocyte Biology, 2008
View PDFchevron_right
Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ib and Fc RIIa in immune thrombocytopenia
Hans Deckmyn
Haematologica, 2013
View PDFchevron_right
The role of Fcγ receptors in murine autoimmune thrombocytopenia
Anja Lux, Markus Biburger, Falk Nimmerjahn
Annals of Hematology, 2010
View PDFchevron_right
PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model
anjali pandey
Blood, 2011
View PDFchevron_right
Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms
Anca Haisan
Medicina
View PDFchevron_right
Multiple concomitant mechanisms contribute to low platelet count in patients with immune thrombocytopenia
Nora Goette
Scientific Reports
View PDFchevron_right
Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice
Hsin-Hou Chang
Blood, 2010
View PDFchevron_right
Platelet Autoantibodies in Immune Thrombocytopenic Purpura
M. Ertem
Transfusion Science, 1998
View PDFchevron_right
The pathogenesis of immune thrombocytopaenic purpura
Nichola Cooper
British Journal of Haematology, 2006
View PDFchevron_right
Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP)
Johan Rebetz
Platelets
View PDFchevron_right
New monoclonal anti-human Fc gamma receptor II antibodies induce platelet aggregation
Koichi Iwata
Clinical & Experimental Immunology, 2008
View PDFchevron_right
Identification of FcRIIa as the ITAM-bearing receptor mediating IIb3 outside-in integrin signaling in human platelets
cunji gao
2008
View PDFchevron_right
Fc Receptor-mediated Platelet Activation Is Dependent on Phosphatidylinositol 3-Kinase Activation and Involves p120cbl
Abdel Saci
Journal of Biological Chemistry, 1999
View PDFchevron_right
New concepts in pathogenesis of primary immune thrombocytopenia
heba ahmed
Sohag Medical Journal
View PDFchevron_right
Immune thrombocytopenia: what can the systems biology and systems physiology offer?
Alexey Martyanov
Systems Biology and Physiology Reports, 2021
View PDFchevron_right
Fcγ receptor expression on splenic macrophages in adult immune thrombocytopenia
Sylvain Audia
Clinical and Experimental Immunology, 2017
View PDFchevron_right
Doc 2 .(ITP) disease in light of advances in Immunology.doc
luvaga dedan
View PDFchevron_right
Rapid ubiquitination of Syk following GPVI activation in platelets
Jianguo Jin
Blood, 2005
View PDFchevron_right
New model of transient strain-dependent autoimmune thrombocytopenia in mice immunized with rat platelets
Hans Deckmyn
Experimental Hematology, 2004
View PDFchevron_right
Platelet Activation and Thrombus Formation over IgG Immune Complexes Requires Integrin αIIbβ3 and Lyn Kinase
Peter Newman
PloS one, 2015
View PDFchevron_right
Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor gamma-chain, Fyn, and Lyn to activate human platelets
Christine Edmead
Blood, 1999
View PDFchevron_right
Glycoprotein Ib-V-IX, a Receptor for von Willebrand Factor, Couples Physically and Functionally to the Fc Receptor γ-Chain, Fyn, and Lyn to Activate Human Platelets
Christine Edmead
Blood, 1999
View PDFchevron_right
The Inflammatory Role of Platelets: Translational Insights from Experimental Studies of Autoimmune Disorders
Beate Kehrel
International Journal of Molecular Sciences, 2016
View PDFchevron_right
Diagnosis, treatment and pathophysiology of autoimmune thrombocytopenias
B. Chong
Critical Reviews in Oncology/Hematology, 1995
View PDFchevron_right
Low platelet counts alone do not cause bleeding in an experimental model of immune thrombocytopenic purpura in mice
Victoria Domínguez
2003
View PDFchevron_right
Inhibition of Fc R-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and Fc RIIb in human macrophages
Iwan Kustiawan, Gestur Vidarsson
Blood, 2014
View PDFchevron_right
Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia
james bussel
Blood, 2011
View PDFchevron_right
Mice Lacking the ITIM-Containing Receptor G6b-B Exhibit Macrothrombocytopenia and Aberrant Platelet Function
Paul Gissen, Alexandra Mazharian, Yotis Senis
Science Signaling, 2012
View PDFchevron_right
Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcR -chain complex from the human platelet surface
Peter Newman
Blood, 2004
View PDFchevron_right
FXR and its ligands inhibit the function of platelets
Neline KRiek
2016
View PDFchevron_right